BDBM63305 4-tert-butyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-ylcarbamothioyl)benzamide::4-tert-butyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-ylthiocarbamoyl)benzamide::4-tert-butyl-N-[sulfanylidene-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-ylamino)methyl]benzamide::MLS000392071::SMR000260995::cid_2410811

SMILES COc1cc(Nc2nc(-c3ccc4cc[nH]c4c3)cn3ncnc23)ccc1N1CC2CC1CN2C1COC1

InChI Key InChIKey=NRCOVFCHCPUKBE-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 63305   

TargetTyrosine-protein kinase SYK(Human)
Nanjing Ruijie Pharma Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 63305BDBM63305(6-(1H-indol-6-yl)-N-(3-methoxy-4-(5-(oxetan-3-yl)-...)
Affinity DataIC50: 50nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent